New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 1, 2016 – Citius Pharmaceuticals announced the discontinuation of Suprenza (phentermine) 15 mg, 30 mg, and 37.5 mg orally disintegrating tablets.
Download PDF
Return to publications
